Company Name: |
ANAXLABORATORIES PRIVATE LIMITED
|
Tel: |
+91-9177075735 |
Email: |
KIRAN.KARNATI@ANAXLAB.COM |
Products Intro: |
Product Name:( 5- ( 4 - ( ( 3 - chloro - 4 - ( ( 3 - fluorobenzyl ) oxy ) phenyl ) amino ) quinazolin - 6 - yl ) furan - 2 - yl ) metha CAS:320337-48-2 Purity:98% Package:1 kg,5 kg, 10 kg,25kg and 1 MT
|
Company Name: |
ChemStrong Scientific Co.,Ltd
|
Tel: |
0755-0755-66853366 13670046396 |
Email: |
sales@chem-strong.com |
Products Intro: |
Product Name:Lapatinib Impurity 2 CAS:320337-48-2 Purity:95% HPLC Package:10mg;25mg;50mg;100mg
|
Company Name: |
Shanghai CR Corporation Limited
|
Tel: |
021-80270511; 4006653949 |
Email: |
fred.wen@crcorporation.cn |
Products Intro: |
Product Name:Lapatinib Desmesylethylamino Hydroxy Imp CAS:320337-48-2
|
|
| Lapatinib IMpurity 8 Basic information |
Product Name: | Lapatinib IMpurity 8 | Synonyms: | Des(sulfonylethyl)amino Hydroxy Lapatinib;Lapatinib Desmesylethylamino Hydroxy Imp;Lapatinib Desmesylethylamino Hydroxy impurity;2-Furanmethanol, 5-[4-[[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]amino]-6-quinazolinyl]-;4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)-6-(5-hydroxymethylfuran-2-yl)quinazoline;5-[4-[[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]amino]-6-quinazolinyl]-2-furanmethanol;( 5- ( 4 - ( ( 3 - chloro - 4 - ( ( 3 - fluorobenzyl ) oxy ) phenyl ) amino ) quinazolin - 6 - yl ) furan - 2 - yl ) metha | CAS: | 320337-48-2 | MF: | C26H19ClFN3O3 | MW: | 475.9 | EINECS: | | Product Categories: | | Mol File: | 320337-48-2.mol | |
| Lapatinib IMpurity 8 Chemical Properties |
Melting point | >150°C (dec) | storage temp. | -20°C Freezer, Under inert atmosphere | solubility | DMSO (Slightly), Methanol (Slightly, Heated, Sonicated) | form | Solid | color | Pale Yellow to Light Yellow |
| Lapatinib IMpurity 8 Usage And Synthesis |
Uses | Des(sulfonylethyl)amino Hydroxy Lapatinib is a compound related to drug Lapatinib (L175808), which is a selective inhibitor of epidermal growth factor receptor (EGFR) and HER-2 tyrosine kinases. Lapatinib is used to treat breast cancer, especially metastatic breast cancer that has progressed after trastuzumab treatment and other chemotherapy. |
| Lapatinib IMpurity 8 Preparation Products And Raw materials |
|